InnoLife Science Scandinavia

A new blood test demonstrated remarkable promise in discriminating between persons with and without Alzheimer’s disease and in persons at known genetic risk may be able to detect the disease as early as 20 years before the onset of cognitive impairment, according to a large international study published today in the Journal of the American Medical Association (JAMA) and...

Comprehensive heart health analytics for greater longevity. Cardiolyse is a cloud ECG & HRV analytics platform, that enables real-time remote heart health monitoring, providing plain personalized reports, detection and up to two months data-based prognosis on dangerous heart events. The solution is using medical grade artificial intelligence algorithms (AI), our patented universal ECG scoring system and personal baseline calculation. CARDIOLYSE.COM

Researchers at the University of Oslo and Oslo University Hospital have discovered how destructive changes occur in our genome. This could lead to cancer. Their results have been published in the journal Nature Cell Biology. All the cells in the body have a nucleus containing the genome. The genome contains all of our genetic information. The nucleus is surrounded by a...

Dossier organizes and documents learning, skills and experience effectively, ensuring operational quality and patient safety. This includes On-the-Job-Training, procedures, e-learning and certifications, as well as end-user introductions to complex digital solutions like EMR/HER and medical devices. We assist more than 350 000 healthcare professionals across the Nordics in reducing time spent on competency management, while assuring compliance.  

The antidepressant fluoxetine has been suggested as a means to improve brain recovery after acute stroke. However, a large randomised study on stroke patients at 35 Swedish hospitals shows that the drug has no such effect. The study, which was led by researchers at Karolinska Institutet, is published in The Lancet Neurology. Erik Lundström, researcher at the Department of Clinical...

A new joint report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) presents the largest venture ever on precision medicine in diabetes. The report includes a detailed overview and roadmap for how this new approach to diabetes medicine can be evaluated and implemented into clinical practice. The role of precision diabetes medicine...

A new way of identifying cancer biomarkers has been developed by researchers at Lund University in Sweden. The new technology allows very sensitive, quick and cost-effective identification of cancer biomarkers. The research is published in Nature Communications Biology. Today, every third person will get cancer in their lifetime, and the current trend suggests that in a few years that number...

Zelluna Immunotherapy is a privately-owned Norwegian biopharmaceutical company founded in 2016. The goal is to revolutionize cancer therapy by developing TCR based immunotherapies with the potential to treat a wide range of solid tumours and patients. Zelluna has a broad portfolio of TCRs derived from both CD4 and CD8 T cell clones. The TCRs have been tailored by the immune system of long-term...

Airinum in Stockholm, Sweden is a successful company that offers an anti-pollution breathing mask to poor air quality, one of the world’s largest indirect health risks according to the World Health Organization . The company has also been boosted by the ongoing COVID-19 pandemic and the global demand for breathing masks. The key to the protection is five layers of protection, each layer with...

NEWS Treatment of the common disease psoriasis, usually focuses on treating the skin. However, psoriasis patients often have other physical diseases that can bring on depression, anxiety, and suicide. A new study from Umeå University, Sweden, shows that these other somatic diseases have even more impact on patients’ mental health than their skin symptoms, highlighting the importance of holistic patient...